bioAffinity Technologies, Inc.
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targe…
Medical - Diagnostics & Research
US, San Antonio [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
bioAffinity Technologies, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDbioAffinity Technologies, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of bioAffinity Technologies, Inc..
If you want to see a demo, head over to the financial segments of AAPL